UBS Lowers Meta Price Target to $650

Analyst: Stephen Ju 1 min read Reproduced verbatim
Rating
Buy
Target
$650
from $786 (−17%)
Outcome
Reached
on May 13, 2025

UBS’s latest target on Meta is now $815 (Nov 17, 2026); the median of 33 firms is $850. UBS has reached 83% of its year-old targets (59 scored).

UBS and Meta logos

What the analyst said

UBS analyst Stephen Ju lowered the price target on Meta Platforms Inc. (NASDAQ: META) to $650 (from $786) while maintaining a Buy rating.

Cite this note: Price Target, "UBS Lowers Meta Price Target to $650," April 11, 2025. https://price-target.com/2025/04/11/176464/
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

META trades at $561. The 33 analysts who set a target in the last 3 months range from $650 to $1,000, with a median of $850. This $650 target is 24% below the median, the lowest on the Street.

Since the note META has moved +3% (from $546). The 12-month window closed on April 11, 2026.

Track record

This call✓ Target reached on May 13, 2025, 32 days after the note.

Firm track recordUBS: 83% of its 59 targets at least a year old were reached within 12 months (#4 of 29 firms); on Meta, 3 of 7. Accuracy ranking →

UBS on Meta

Share Reddit StockTwits
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.